Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Generex Biotechnology Corporation (OP: GNBT)
0.0270 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 20, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Generex Biotechnology Corporation
 
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Generex Biotechnology VP, Medical Affairs, Presents Generex Oral-lyn(TM) at Lebanese Scientific Congress
May 17, 2007
from Marketwired News Releases
Generex Biotechnology to Present at Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference
May 14, 2007
from Marketwired News Releases
Generex Biotechnology Receives Strong Interest From Leading National and Regional Retailers, Drug Stores and Wholesalers for Its OTC Line
May 14, 2007
Generex Preparing for North America and International Expansion and Launch of Its OTC line Read More
from Marketwired News Releases
Generex Biotechnology Announces Launch of Two OTC Products at Leading Healthcare Industry Event
May 07, 2007
from Marketwired News Releases
Generex Biotechnology Announces Treatment of First Breast Cancer Patients in Phase II Clinical Trial
May 02, 2007
Trial of Second Generation Immunotherapeutic Vaccine Being Conducted With U.S. Military Cancer Institute's Clinical Trials Group Read More
from Marketwired News Releases
Generex Biotechnology to Ring NASDAQ Closing Bell on May 2nd
April 30, 2007
from Marketwired News Releases
Generex Biotechnology Announces Middle Eastern Distribution Arrangement for Glucose RapidSpray(TM)
April 26, 2007
Product to Be Distributed in 15 Countries Read More
from Marketwired News Releases
Generex Biotechnology to Make Presentations at the 2nd International Congress on "Prediabetes" and the Metabolic Syndrome
April 24, 2007
from Marketwired News Releases
Generex Biotechnology Announces Middle Eastern Licensing Agreement for Generex Oral-lyn(TM)
April 23, 2007
Leading Middle Eastern Distributor of Healthcare Products to Offer Generex Oral-lyn in 15 Countries Read More
from Marketwired News Releases
Generex Biotechnology Granted Patents in Canada and Mexico
April 20, 2007
Company Expands North American Drug Delivery Platform Patent Portfolio Read More
from Marketwired News Releases
Generex Biotechnology Vaccine Development Programs Presented at the Annual Meeting of the American Association for Cancer Research
April 16, 2007
from Marketwired News Releases
Generex Biotechnology to Make Presentations at the American Association of Clinical Endocrinologists 16th Annual Meeting & Clinical Congress
April 11, 2007
from Marketwired News Releases
Generex Biotechnology to Present Data at 4th International Symposium on Diabetes and Pregnancy
March 29, 2007
from Marketwired News Releases
Generex Executive Discusses RNAi Platform in Online Interview
March 27, 2007
from Marketwired News Releases
Generex Biotechnology to Test Novel RNAi-Based Immune-Response Strategy in Cancer Patients
March 26, 2007
Clinical Trials to Be Conducted in Beijing, China With Renowned Hematologist Read More
from Marketwired News Releases
Torc Investments and Research Reiterates "Buy" Rating on Generex Biotechnology and $3.00-$3.50 12-Month Price Target
March 20, 2007
from Marketwired News Releases
Generex Scientist to Present on the Status of Influenza Vaccine Development at National Conference
March 19, 2007
from Marketwired News Releases
Generex Biotechnology Granted Patents in Canada and Europe
March 13, 2007
Company Expands Drug Delivery Platform Patent Portfolio in Canada and Europe Read More
from Marketwired News Releases
38th NAACP Image Awards Feature Generex Biotechnology's Pipeline of Diabetes Products
March 05, 2007
from Marketwired News Releases
Jesup & Lamont Initiates Coverage of Generex Biotechnology With "Buy" Rating and Price Target of $3.25
February 22, 2007
from Marketwired News Releases
Generex Biotechnology Expands Glucose RapidSpray(TM) Distribution
February 20, 2007
from Marketwired News Releases
Generex Biotechnology Extends Scope of U.S. Patent Protection for Vaccine Technology
February 13, 2007
Notice of Allowance Issued by USPTO for Ii-Key Hybrid Design Technology and Use Read More
from Marketwired News Releases
Frost & Sullivan Acknowledges Generex's Path-breaking Innovations in Oral Insulin Spray Technology
February 07, 2007
from PR Newswire
Wall Street News Alert: ERUG is Monday's Stock to Watch! January 22, 2007
January 22, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding. Read More
from Marketwired News Releases
Generex Biotechnology to Make Presentation at 3rd Annual Diabetes 2007
January 16, 2007
from Marketwired News Releases
Torc Investments and Research Reiterates Buy Rating for Generex Biotechnology 12-Month Price Target of $3.00-$3.50
December 18, 2006
from Marketwired News Releases
Wall Street News Alert: Breaking News Alert - GTHA! December 15, 2006
December 15, 2006
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding. Read More
from Marketwired News Releases
Clinical Trial Results From Cancer Vaccine Being Developed by Generex Biotechnology Subsidiary to Be Presented at San Antonio Breast Cancer Symposium
December 14, 2006
from Marketwired News Releases
Generex Biotechnology Selects Inyx to Produce Glucose RapidSpray(TM) for Worldwide Markets
December 07, 2006
from PR Newswire
Generex Biotechnology Selects INYX to Produce Glucose RapidSpray(TM) for Worldwide Markets
December 07, 2006
from Marketwired News Releases
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here